MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Does ‘DYT23’ exist? Report of a second family with adult- onset focal dystonia and a CACNA1AB mutation – causative or coincidental?

    P. Agarwal, M. Desai, S. Ravat (Mumbai, India)

    Objective: To describe clinical and genetic findings in a patient with focal adult-onset primary cranial dystonia and chorea, and a mutation in CACNA1B (also referred…
  • 2018 International Congress

    Comorbidity and retirement in primary focal cervical dystonia

    R. Ortiz, F. Scheperjans, T. Mertsalmi, E. Pekkonen (Helsinki, Finland)

    Objective: The objective of this study was to investigate comorbidities in cervical dystonia (CD) and effect of CD to retirement rate in Finland. Background: Cervical…
  • 2018 International Congress

    The Characteristics of Patients with Movement Disorders in a Diverse Inner-City Hospital

    L. Nwabuobi, J. Agee, M. Ko, R. Gilbert (New York, NY, USA)

    Objective: To investigate healthcare disparities in provision of care to Parkinson's disease (PD) and PD-plus patients in an ethnically diverse population in an inner-city hospital.…
  • 2018 International Congress

    Antihypertensive medications have protective associations with PD outcomes in PD-hypertension

    V. Kotagal (Ann Arbor, MI, USA)

    Objective: We explored the associations between markers of clinical decline and antihypertensive use in subjects with both Parkinson disease (PD) and hypertension (HTN) Background: Comorbid…
  • 2018 International Congress

    Pharmacological investigation of biochemical and behavioral effects resembling Huntington’s disease utilizing selective calcium and calmodulin dependent phosphodiesterase inhibitor

    R. Mishra (Baddi, India)

    Objective: To investigate the effects of selective phosphodiestrase (PDE) inhibitors in Nimodipine induced neuro degeneration (animal models of Huntington’s disease) in rats. Background: Nimodipine is…
  • 2018 International Congress

    A Study on Combined Brain Positron Emission Tomography (PET) – Magnetic Resonance Imaging (MRI) Using Fluorodeoxyglucose (18FDG) (FDG-PET/MRI) in Premanifest Huntington’s Disease Gene-expansion Carriers

    M. Hellem, T. Vinther-Jensen, C. Hansen, E. Budtz-Jørgensen, L. Hjermind, I. Law, J. Nielsen (Copenhagen, Denmark)

    Objective: By a combined brain PET–MRI using FDG, we wished to simultaneously characterize the structural and metabolic brain changes in premanifest HD gene-expansion carriers. Background:…
  • 2018 International Congress

    Sniffing Parkinson’s in the masses: Volatilome analysis for Parkinson’s Disease diagnostics

    M. Silverdale, D. Trivedi, E. Sinclair, Y. Xu, C. Liscio, P. Banks, T. Kunath, R. Goodacre, P. Barran (Manchester, United Kingdom)

    Objective: To identify volatile compounds in the skin which can be used to provide an early diagnosis in Parkinson's disease (PD). Background: There is a…
  • 2018 International Congress

    Approaching Health Care Shaped by Generational Expectations (The AGE Study): A perspective on technology and research

    T. Rasameesoraj, D. Hengartner, J. Lin, O. Hogue, E. LaPlante, Y. Li, O. Wenzel, J. Liang, H. Fernandez, X. Yu (Cleveland, OH, USA)

    Objective: To determine if different generational groups (Traditionalists, Baby Boomers, Generation Xers, and Millennials) have different preferences regarding healthcare system and providers, particularly their perspectives…
  • 2018 International Congress

    Four eyelid and eye movement disorder cases misdiagnosed as seronegative ocular myasthenia gravis

    M. Kamada, K. Kume (Kita-gun, Japan)

    Objective: To report four eyelid and eye movement disorder cases misdiagnosed as seronegative ocular myasthenia gravis. Background: Myasthenia gravis (MG) is a disorder where neurotransmission…
  • 2018 International Congress

    Effects of Aquatic Physical Therapy on Parkinson’s disease under a vision of the International Classification of Functioning, Disability and Health (ICF)

    V. Israel, B. Yamaguchi, M. Ferreira (Curitiba, Brazil)

    Objective: The objective of the study was to verify the effects of APT on functional abilities of people with PD. Background: In the biopsychosocial model…
  • « Previous Page
  • 1
  • …
  • 51
  • 52
  • 53
  • 54
  • 55
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley